Mackmyra's Intelligens is billed as the first whisky created using artificial intelligence. But have they tried using it to make whisky? We now know that they have, although drinkers in the U.S. will have to wait to judge how the AI experiment turned out. Source: How Microsoft got in on the creation of the world's first whisky formulated with AI

AI is the future, and it's also the past. Not just in the sense of having been developed in previous years and decades, but also in the sense of being capable of recreating human history. This power was highlighted vividly by a study published at the end of August by researchers from University College London and Duke University, who managed to use artificial intelligence to create separate representations of two images that had been painted on both sides of a single panel. More specifically, they used X-ray imaging techniques to produce a combined representation of the outer panels of the famous 15th Century Ghent Altarpiece painting. Because the resulting image was a combination of two images superimposed on each other, it was previously hard to analyze.

Hong Kong, Leading AI company SingularityNET has announced the release of its the Beta V2 version of its decentralized AI platform, which lets anyone create, share, and deploy AI services at scale. The release features a revamped user interface, as well as significant back-end technical upgrades designed to facilitate a smooth developer and end-user onboarding experience. The V2 includes technical and design upgrades plus genetics and computer vision tools. The V2 release also features a broad library of AI services, applying open-source AI tools to images, texts and genomic data for a variety of practical purposes. The upgraded Genomic Annotation Service, produced in partnership with Mozi AI Health, features additional biological ontologies that researchers can use to connect their genetic analysis results to biomedical databases integrated within the OpenCog AGI Engine.

The Department of Energy and the Weill Family Foundation on Monday signed a memorandum of understanding for a new public-private partnership which will use the agency's artificial intelligence capabilities for biomedical research. Former Citigroup CEO Sandy Weill and Energy Secretary Rick Perry told CNBC's "Closing Bell" in an exclusive interview that the partnership aims to improve the diagnosis of brain diseases and neurological disorders, which would result in more effective treatment. "As one looks at science and the development of new science, especially AI and computing, you really need to have partners to make things work." "It's too expensive for anybody to try to do it by themselves." The partnership between the federal government and the Weill Family Foundation, involves Lawrence Livermore, Lawrence Berkeley and Argonne National laboratories, and was announced during a roundtable on DOE-fueled artificial intelligence at Lawrence Livermore Lab in Livermore, California.

This further weakens Europe since most of the companies doing top research in this field are controlled from the US (or China) – many European companies whose future business crucially depends on AI are not perceived as competitive.

Intelligent Process Automation Market Highlights: The growing adoption of automation in different industries has created a lot of opportunities for newer technologies. These technologies enable intelligent process automation by combining basic process design with robotic process automation. In addition to the intelligent or robotic process automation, machine learning and deep learning also contribute towards the growth of the market to a greater extent. These technologies help an enterprise to re-structure their business functions and further make improvements in the business operation process. The major factors contributing to the growth of intelligent process automation is the growing adoption of automation and robotics in manufacturing industries, and integration of internet of things to improve the efficiency and effectiveness of the manufacturing process.

VSBLTY Groupe Technologies Corp. (CSE:VSBY) (OTC:VSBGF) (5VS.F) is uniquely positioned to facilitate the growth of smart city technology in the Latin American market, according to company co-founder and CEO Jay Hutton. This will be made possible through the company's just announced three-year agreement with intelligent lighting solutions provider Energetika. VSBLTY is to provide real time crowd analytics and audience measurement for Latin American communities. Hutton explained how VSBLTY's technology is ideal for the growth of smart cities in the region. "If you think of smart cities as a three-legged stool: the one leg is information, the second is analytics and the third is facial recognition for the purposes of law enforcement," said Hutton.

IRCAM, the world's largest research center dedicated to both musical expression and scientific research, is a partner of the Ars Electronica Festival 2019. The institution is also involved in the STARTS Initiative as coordinator of the STARTS Residencies and will present these activities at the STARTS Day. Hugues Vinet, head of research activities at IRCAM, told us in an interview how the institute works, why AI has social relevance and what role he and his team will play at the festival. Hugues Vinet: My background is signal processing. I worked from the mid 1980s at the Musical Research Group (GRM) in Paris on the first real-time audio workstations and I designed the early versions of the GRM Tools product which made creative audio processing tools broadly available on personal computers.

Robot-assisted surgery, preventive medical intervention (based on predictive diagnostics) and virtual nursing assistants are just some of the many applications where AI is predicted to transform delivery of healthcare over the next decade. However, too much of the current narrative around AI remains'futuristic', exploring the potential benefits of future R&D and innovation, rather than focusing on the real benefits that AI could and should be delivering to healthcare providers today. Without doubt, the prospect of AI being used within frontline clinical care is exciting and awe-inspiring, with companies like doc.ai (which uses AI to predict an individual's health risks) working on some genuinely game-changing innovation. However, for an industry that is suffering the consequences of monumental budgetary and staffing challenges on a daily basis, it's simply not enough to be looking 10 years down the road; healthcare providers need solutions to these problems today. The fact is that AI technology has already reached a level of maturity where it can deliver huge value to the healthcare industry and across social care and all public services.

Swapna is a Product Lead at RBC in Canada, leading their innovation stream to create products and digital solutions using lean methodologies. Her current focus is on solving user identity management, goal based planning, personalization and digital transformation use-cases for RBC. Prior to RBC, Swapna was the Head of Product at a UK-based SaaS Data intelligence company, Klood that provided insights out of complex unstructured datasets to enterprise clients through artificial intelligence. Whilst in Singapore, Swapna was responsible for driving Ecommerce growth for the Asian and European regions for the world's largest publishing company, Scholastic as their Product Manager. She started her career with Accenture, and is a technology buff.